Chugai Pharmaceutical Statistics

Total Valuation

CHGCF has a market cap or net worth of 76.29 billion. The enterprise value is 69.85 billion.

Market Cap	76.29B
Enterprise Value	69.85B

Important Dates

The next estimated earnings date is Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	1.65B
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	639.69M

Valuation Ratios

The trailing PE ratio is 27.85.

PE Ratio	27.85
Forward PE	n/a
PS Ratio	9.35
PB Ratio	5.99
P/TBV Ratio	6.04
P/FCF Ratio	32.38
P/OCF Ratio	27.64
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.80, with an EV/FCF ratio of 29.65.

EV / Earnings	25.50
EV / Sales	8.39
EV / EBITDA	16.80
EV / EBIT	17.72
EV / FCF	29.65

Financial Position

The company has a current ratio of 7.28

Current Ratio	7.28
Quick Ratio	5.95
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 23.11% and return on invested capital (ROIC) is 20.38%.

Return on Equity (ROE)	23.11%
Return on Assets (ROA)	17.92%
Return on Invested Capital (ROIC)	20.38%
Return on Capital Employed (ROCE)	29.97%
Revenue Per Employee	1.62M
Profits Per Employee	544,953
Employee Count	5,026
Asset Turnover	0.61
Inventory Turnover	1.39

Taxes

In the past 12 months, CHGCF has paid 1.13 billion in taxes.

Income Tax	1.13B
Effective Tax Rate	29.16%

Stock Price Statistics

The stock price has increased by +32.45% in the last 52 weeks. The beta is 0.67, so CHGCF's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+32.45%
50-Day Moving Average	53.38
200-Day Moving Average	45.80
Relative Strength Index (RSI)	48.16
Average Volume (20 Days)	1,602

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CHGCF had revenue of 8.16 billion and earned 2.74 billion in profits. Earnings per share was 1.66.

Revenue	8.16B
Gross Profit	5.80B
Operating Income	3.87B
Pretax Income	3.87B
Net Income	2.74B
EBITDA	4.04B
EBIT	3.87B
Earnings Per Share (EPS)	1.66

Full Income Statement

Balance Sheet

The company has 6.31 billion in cash and n/a in debt, giving a net cash position of 6.31 billion.

Cash & Cash Equivalents	6.31B
Total Debt	n/a
Net Cash	6.31B
Net Cash Per Share	n/a
Equity (Book Value)	12.74B
Book Value Per Share	7.74
Working Capital	8.73B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.76 billion and capital expenditures -404.37 million, giving a free cash flow of 2.36 billion.

Operating Cash Flow	2.76B
Capital Expenditures	-404.37M
Free Cash Flow	2.36B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.01%, with operating and profit margins of 47.36% and 33.56%.

Gross Margin	71.01%
Operating Margin	47.36%
Pretax Margin	47.37%
Profit Margin	33.56%
EBITDA Margin	49.52%
EBIT Margin	47.36%
FCF Margin	28.87%

Dividends & Yields

This stock pays an annual dividend of 1.23, which amounts to a dividend yield of 2.62%.

Dividend Per Share	1.23
Dividend Yield	2.62%
Dividend Growth (YoY)	127.47%
Years of Dividend Growth	1
Payout Ratio	39.42%
Buyback Yield	-0.01%
Shareholder Yield	2.62%
Earnings Yield	3.59%
FCF Yield	3.09%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CHGCF has an Altman Z-Score of 30.4 and a Piotroski F-Score of 7.

Altman Z-Score	30.4
Piotroski F-Score	7